TOTAL              265
and                  CC             13 
technologies         NN2             9 
of                   IO              9 
Althea               NP1             7 
a                    AT1             7 
development          NN1             6 
for                  IF              5 
inc                  JJ              4 
the                  AT              4 
Ajinomoto_Co.        NP1             4 
in                   II              4 
Ajinomoto_Co         NP1             3 
services             NN2             3 
althea               NN1             3 
about                II              3 
is                   VBZ             3 
product              NN1             3 
offers               VVZ             3 
formulation          NN1             3 
SAN_DIEGO            NP1             2 
TYO                  NP1             2 
2802                 MC              2 
manufacturing        NN1             2 
at                   II              2 
fully                RR              2 
company              NN1             2 
Ajinomoto_Althea     NP1             2 
global               JJ              2 
food                 NN1             2 
human                JJ              2 
health               NN1             2 
billion              NNO             2 
more                 DAR             2 
visit                VV0             2 
release              NN1             2 
technology           NN1             2 
that                 CST             2 
d--                  JJ              1 
ajinomoto            NN1             1 
co.                  NN1             1 
have                 VH0             1 
completed            VVN             1 
previously           RR              1 
announced            VVN             1 
acquisition          NN1             1 
leading              JJ              1 
provider             NN1             1 
biopharmaceutical    JJ              1 
logo                 NN1             1 
http                 NNU             1 
**49;7;toolong       NN1             1 
Ajinomoto            NP1             1 
acquired             VVD             1 
all                  DB              1 
capital              NN1             1 
stock                NN1             1 
closing              VVG             1 
purchase             NN1             1 
price                NN1             1 
approximately        RR              1 
$175_million         NNU             1 
dollars              NNU2            1 
USD                  NP1             1 
will                 VM              1 
become               VVI             1 
consolidated         JJ              1 
subsidiary           NN1             1 
inc.                 JJ              1 
operating            NN1             1 
under                II              1 
name                 NN1             1 
manufacturer         NN1             1 
high-quality         JJ              1 
seasonings           NN2             1 
processed            JJ              1 
foods                NN2             1 
beverages            NN2             1 
amino_acids          NN1             1 
pharmaceuticals      NN2             1 
specialty            NN1             1 
chemicals            NN2             1 
for_many_decades     IF              1 
has                  VHZ             1 
contributed          VVN             1 
to                   II              1 
culture              NN1             1 
through              II              1 
wide-ranging         JJ              1 
application          NN1             1 
amino_acid           NN1             1 
today                RT              1 
becoming             VVG             1 
increasingly         RR              1 
involved             JJ              1 
with                 IW              1 
solutions            NN2             1 
improved             JJ              1 
resources            NN2             1 
sustainability       NN1             1 
founded              VVN             1 
1909                 MC              1 
now                  RT              1 
operating            VVG             1 
26                   MC              1 
countries            NN2             1 
had                  VHD             1 
net                  JJ              1 
sales                NN              1 
JYP_1,197.3          NP1             1 
USD_15.1             NP1             1 
fiscal               JJ              1 
2011                 MC              1 
www.ajinomoto.com    NNU             1 
integrated           VVN             1 
contract             NN1             1 
organization         NN1             1 
located              VVN             1 
CA                   NP1             1 
providing            VVG             1 
clinical             JJ              1 
commercial           JJ              1 
cgmp                 NNU             1 
drug                 NN1             1 
filling_in           VVG             1 
both                 RR              1 
vials                NN2             1 
syringes             NN2             1 
production           NN1             1 
microbial-derived    JJ              1 
recombinant          JJ              1 
proteins             NN2             1 
plasmid              NN1             1 
dna                  NN1             1 
in_conjunction_with  II31            1 
these                DD2             1 
manufacturing        VVG             1 
operations           NN2             1 
comprehensive        JJ              1 
including            II              1 
upstream             RL              1 
downstream           JJ              1 
process              NN1             1 
analytical           JJ              1 
lyophilization       NN1             1 
cycle                NN1             1 
complex              JJ              1 
ich-compliant        JJ              1 
stability            NN1             1 
testing              NN1             1 
'                    GE              1 
platform             NN1             1 
includes             VVZ             1 
Crystalomics         NP1             1 
proprietary          JJ              1 
solution             NN1             1 
large                JJ              1 
molecule             NN1             1 
products             NN2             1 
must                 VM              1 
be                   VBI             1 
delivered            VVN             1 
high                 JJ              1 
concentrations       NN2             1 
or                   CC              1 
as                   RG              1 
sustained            JJ              1 
formulations         NN2             1 
information          NN1             1 
www.altheatech.com   NNU             1 
source               NN1             1 
